Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Zealthy
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxZealthy
Shoppers with insurance who want Zealthy's coordination team to chase brand-name coverage, rather than those seeking the lowest simple cash price.
Visit ZealthyThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 42. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Zealthy still earns a C — Shoppers with insurance who want Zealthy's coordination team to chase brand-name coverage, rather than those seeking the lowest simple cash price.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Zealthy |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 42/100 |
| Semaglutide / mo | $99/mo | $297/mo (bundle, plus a separate fee, compounded) |
| Tirzepatide / mo | $149/mo | $449/mo (bundle, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $3,564 |
| Tirzepatide / yr (modeled) | $1,788 | $5,388 |
| Coverage | All 50 states | 34 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #1 | #517 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Zealthy
42/100Where the value is
- Offers a genuine insurance-coordination path for branded Wegovy/Zepbound/Ozempic/Mounjaro, unlike most other companies in this batch which are cash-pay compounded-only
- The all-in 'Doctor + GLP-1' bundle is transparent about being all-in and includes a stated full-refund policy 'no questions asked' if a patient is found clinically ineligible
- Broader platform than a single-purpose GLP-1 shop — primary care, mental health, and other services are available under the same account
The tradeoffs
- The site's most prominent headline price ($151/month semaglutide, $216/month tirzepatide) requires a 3-month prepay AND excludes a separate membership fee whose dollar amount is not disclosed anywhere in the weight-loss FAQ — a naive reader would not know a second charge exists
- The true all-in monthly cost is $297 (semaglutide) or $449 (tirzepatide) via the bundled plan, roughly double the advertised a la carte headline figure
Regulatory note: the FDA issued a warning letter to FitRX, LLC dba Zealthy in September 2025. We still list and link to Zealthy; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.